Cryo-Cell International, Inc. ( CCEL) - Key Metrics
CCEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.97 | $0.16 | $0.14 | $0.13 |
| 2026Q2 | $0.97 | $0.07 | $0.23 | $0.23 |
| 2026Q1 | $0.95 | $0.01 | $0.08 | $0.07 |
| 2025Q4 | $0.97 | -$0.58 | $0.16 | $0.15 |
| 2025Q3 | $0.97 | $0.20 | $0.31 | $0.31 |
CCEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | 6.56 |
| 2026Q2 | 0% | 12.68 |
| 2026Q1 | 0% | 146.55 |
| 2025Q4 | 0% | -2.16 |
| 2025Q3 | 0% | 13.06 |
CCEL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 3.07% | 0% |
| 2026Q2 | 6.34% | 0% |
| 2026Q1 | 2.14% | 0% |
| 2025Q4 | 3.78% | 0% |
| 2025Q3 | 6.60% | 0% |
CCEL
Price: $4.49
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.23 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 6000
Market Capitalization: 29.4 million
Average Dividend Frequency: 4
Years Paying Dividends: 2